Medicare Enrolled

Dr. Daisy Acevedo Morales, MD

Endocrinology · South Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
6141 SUNSET DR STE 403, South Miami, FL 33143
3056652300
In practice since 2009 (16 years)
NPI: 1891938429 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Acevedo Morales from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Acevedo Morales? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Acevedo Morales

Dr. Daisy Acevedo Morales is an endocrinology in South Miami, FL, with 16 years in practice. Based on federal Medicare data, Dr. Acevedo Morales performed 1,190 Medicare services across 431 unique beneficiaries.

Between the years covered by Open Payments, Dr. Acevedo Morales received a total of $8,976 from 45 pharmaceutical and/or device companies across 382 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Acevedo Morales is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 39% volume in FL$ $8,976 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,190
Medicare services
Top 39% in FL for endocrinology
431
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~74 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)720$19$46
Office visit, established patient (30-39 min)157$99$348
New patient office visit (45-59 min)55$140$541
Blood draw (venipuncture)45$8$9
New patient office visit, complex (60-74 min)43$161$681
Ultrasound scan of head and neck soft tissue41$95$369
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report26$30$140
Blood glucose (sugar) test performed by hand-held instrument25$3$10
Office visit, established patient (20-29 min)25$78$236
Office visit, established patient, complex (40-54 min)25$154$468
Fine needle aspiration biopsy using ultrasound guidance, first growth16$120$729
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle12$59$240
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,976
Total received (2018-2024)
Avg $1,282/year across 7 years
Top 33% in FL for endocrinology
45
Companies
382
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,951 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,947
2023
$2,215
2022
$584
2021
$929
2020
$318
2019
$495
2018
$487

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$1,425
Lilly USA, LLC
$974
Amgen Inc.
$466
SANOFI-AVENTIS U.S. LLC
$454
Janssen Pharmaceuticals, Inc
$441
Insulet Corporation
$355
Dexcom, Inc.
$350
Bayer Healthcare Pharmaceuticals Inc.
$314
AstraZeneca Pharmaceuticals LP
$311
Tandem Diabetes Care, Inc.
$306
Boehringer Ingelheim Pharmaceuticals, Inc.
$294
RECORDATI_RARE_DISEASES_INC.
$268
Xeris Pharmaceuticals, Inc.
$250
Mannkind Corporation
$242
Radius Health, Inc.
$235
MannKind Corporation
$211
Abbott Laboratories
$206
Corcept Therapeutics
$188
PFIZER INC.
$174
Amneal Pharmaceuticals LLC
$159
CeQur Corporation
$145
ABBVIE INC.
$120
Shire North American Group Inc
$119
Medtronic MiniMed, Inc.
$109
BETA BIONICS, INC.
$105
AbbVie Inc.
$95
Embecta Corp.
$85
IBSA Pharma Inc.
$76
Supernus Pharmaceuticals, Inc.
$67
Antares Pharma, Inc.
$62
Kyowa Kirin, Inc.
$49
Alvogen Inc
$46
Medtronic, Inc.
$38
VIVUS LLC
$38
Bayer HealthCare Pharmaceuticals Inc.
$23
Chiesi USA, Inc.
$22
Verity Pharmaceuticals Inc.
$21
Hologic Sales and Service, LLC
$20
Horizon Therapeutics plc
$18
Astellas Pharma US Inc
$18
Nevro Corp.
$17
Mission Pharmacal Company
$17
Acella Pharmaceuticals, LLC
$15
BOSTON SCIENTIFIC CORPORATION
$14
Tolmar, Inc.
$14
Top 3 companies account for 31.9% of total payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano 2nd Gen Pen Needle · CeQur Simplicity · CitraNatal · Corlanor · Crysvita · DEXCOM G7 GSS (161) · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · ELIQUIS · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GVOKE HYPOPEN · GVOKE PFS · ISTURISA · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · LO LOESTRIN FE · LUX DX · MINIMED 780G · MOUNJARO · MYCAPSSA · MYCARELINK · Minimed Paradigm Revel · NP Thyroid 60 · ORILISSA · Omnia · Omnipod · Ozempic · PANCREAZE · QSYMIA · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMAVERT · SYNJARDY · SYNTHROID · TEPEZZA · TERIPARATIDE · THINPREP 2000 PROCESSOR · TOUJEO · TRADJENTA · TZIELD · Tirosint · Tlando · Tresiba · UNITHROID · Veozah · Wegovy · XARELTO · XIGDUO · XYOSTED · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $754 per 100 Medicare services performed
Looking for a endocrinology in South Miami?
Compare endocrinologys in the South Miami area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
106
Per 100K population
3.9
County median income
$68,694
Nearest hospital
SOUTH MIAMI HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Acevedo Morales is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Acevedo Morales experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Acevedo Morales performed 720 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Acevedo Morales receive payments from pharmaceutical companies?
Yes. Dr. Acevedo Morales received a total of $8,976 from 45 companies across 382 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Acevedo Morales's costs compare to other endocrinologys in South Miami?
Dr. Acevedo Morales's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Acevedo Morales) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →